Clinical Trial Update: Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension [Phase 2]

View source ↗

Summary

Phase 2 study assessing efficacy and safety of irbesartan and amlodipine combined or alone in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Irbesartan (irbesartan)

Snippet

Sponsor: Handok Inc. | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED